pafenolol

structure given in first source

Networked: 3 relevant articles (0 outcomes, 1 trials/studies)

1.	Hypertension (High Blood Pressure) 01/01/1984 - "Pafenolol, a new beta 1-selective blocking agent, in mild hypertension. " 01/01/1986 - "Pafenolol in hypertension: a double-blind randomized trial of a new beta 1-selective adrenoceptor blocker."
2.	Tachycardia (Tachyarrhythmias) 01/01/1983 - "The reflex tachycardia on terbutaline stimulation after pafenolol was greater than after metoprolol due to less blockade of beta 2-adrenoceptors in peripheral blood vessels. "
3.	Essential Hypertension 01/01/1986 - "Twenty-three patients with essential hypertension, mean age 49 years (range 21-62), were randomized after a 4-week placebo run-in period (double-blind) to 4 weeks of either placebo, pafenolol 50 mg or 100 mg once daily. "

1.	Adrenergic Receptors (Adrenergic Receptor)
2.	Terbutaline (Brethaire)
3.	Metoprolol (Toprol-XL)